Pathstone Family Office’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-944	Closed	-$9.95K	–	1281
2023 Q1	$9.95K	Sell	944 -1,601	-63%	-$16.9K	﹤0.01%	1181
2022 Q4	$86.1K	Buy	+2,545	New	+$86.1K	﹤0.01%	1447